Evidence map›Paper›PMID 27025645›Full record

ReviewAntibiotics (Basel, Switzerland)2015

Examining the Clinical Effectiveness of Non-Carbapenem β-Lactams for the Treatment of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae.

Allison M Gibble, Alan E Gross, Angela M Huang

Open access · goldAbstract readReview
In one paragraph

Review in Antibiotics (Basel, Switzerland), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 59% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Allison M GibbleDepartment of Pharmacy, Froedtert & The Medical College of Wisconsin, 9200 W. Wisconsin Ave, Milwaukee, WI 53226, USA. allison.gibble@froedtert.com.
Alan E GrossDepartment of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, 833 S. Wood St., 164 PHARM, Chicago, IL 60612, USA. aegross@uic.edu.
Angela M HuangDepartment of Pharmacy, Froedtert & The Medical College of Wisconsin, 9200 W. Wisconsin Ave, Milwaukee, WI 53226, USA. angela.huang@froedtert.com.
Medical College of Wisconsin · USUniversity of Illinois Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatment options for extended-spectrum β-lactamase-producing Enterobacteriaceae are limited. Piperacillin-tazobactam and cefepime represent potential alternative treatment options; however, large prospective studies are lacking. This review evaluates the current literature regarding use of piperacillin-tazobactam and cefepime for the treatment of extended-spectrum β-lactamase-producing Enterobacteriaceae. Antimicrobial stewardship programs can play a key role in guiding the best practices for the management of these challenging infections.

Indexed as

carbapenemscefepimeextended-spectrum beta-lactamasespiperacillin-tazobactam

Identifiers

PMID27025645
PMCPMC4790318
OpenAlexW2221368405

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.